Changes in glomerular eicosanoid production have been implicated in the development of diabetes-induced glomerular hyperfiltration and glomerular mesangial cells (GMC) are major eicosanoid-producing cells within the glomerulus. However, the mechanism for the effect of diabetes mellitus on glomerular mesangial eicosanoid production is unknown. The present study therefore examined whether elevated glucose concentrations activate protein kinase C (PKC) in GMC and whether this PKC activation mediates an effect of elevated glucose concentrations to increase the release of arachidonic acid and eicosanoid production by GMC. The percentage of [3H]arachidonic acid release per 30 min by preloaded GMC monolayers was significantly increased after 3-h exposure to high glucose (20 mM) medium (177% vs control medium) and this increase was sustained after 24-h exposure to high glucose concentrations. 3-h and 24-h exposure to high glucose medium also increased PGE2, 6-keto-PGF1 alpha, and thromboxane (TXB2) production by GMC. High glucose medium (20 mM) increased PKC activity in GMC at 3 and 24 h (168% vs control). In contrast, osmotic control media containing either L-glucose or mannitol did not increase arachidonic acid release, eicosanoid production, or PKC activity in GMC. Inhibiting glucose-induced PKC activation with either H-7 (50 microM) or staurosporine (1 microM) prevented glucose-induced increases in arachidonic acid release and eicosanoid production by GMC. These data demonstrate that elevated extracellular glucose concentrations directly increase the 
Introduction
Diabetes mellitus in experimental animals and humans is associated with qualitative and quantitative changes in PG and TX production by many tissues (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . With regard to the kidney, previous studies demonstrate increased production of PGE2, 6 -keto-PGFia, and TXB2 by glomeruli isolated from rats with early streptozotocin-induced diabetes mellitus (8, 9, (11) (12) (13) .
These changes have in turn been implicated in the pathogenesis of glomerular hemodynamic abnormalities that may play a role in the development ofdiabetic glomerulopathy (8, 9, 12, 14) .
The mechanisms responsible for diabetes-induced changes in glomerular eicosanoid production are unclear but may depend on increased release of arachidonic acid (8, 9) , perhaps via diabetes-induced increases in glomerular phospholipase A2 activity ( 1 5 ). Thus far, however, the factors and mechanisms responsible for these diabetes-induced increases in PLA2 activity and arachidonic acid release are unknown. Hyperglycemia is the hallmark of diabetes mellitus, thus glucose has to be considered as a potential mediator of increased glomerular eicosanoid production. In this regard, a previous study has shown that when exposed to elevated extracellular glucose concentrations, cultured glomerular mesangial cells (GMC)' produce increased quantities of prostaglandin, predominantly PGE2 (9) .
The GMC is a major prostanoid-producing cell within the glomerulus and the rate ofendogenous arachidonic acid release is usually rate limiting for GMC eicosanoid synthesis ( 16) .
Recent evidence suggests that activation of the calcium/phospholipid-dependent protein kinase C system (PKC) plays a key role in regulating arachidonic acid release by many cell types, including GMC (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) . Moreover, PKC activation may also increase PGE2 production by GMC ( 17, 26, 27) . These observations are intriguing because high glucose concentrations have been shown to increase PKC activity in many tissues in vivo and in many cell types in vitro (28) (29) (30) (31) (32) (33) .
Taken together, the aforementioned observations suggest that glucose may directly influence GMC arachidonic acid release and eicosanoid production via mechanisms dependent on glucose-induced PKC activation. Examining this hypothesis in vivo would be impossible because diabetes mellitus is associated with a myriad of metabolic and hormonal changes that could influence PKC activity and eicosanoid production by GMC. Thus, the present study uses cultured GMC in vitro to test the hypothesis that elevated extracellular glucose concentrations directly increase arachidonic acid release and prostaglandin production by GMC via mechanisms dependent on glucose-induced PKC activation.
Methods
Glomerular mesangial cell culture GMC were cultured from glomeruli isolated from 200-300-g nondiabetic Sprague Dawley rats as previously described in detail (34, 35) .
The GMC were grown as monolayers on 35 -mm culture dishes in RPMI 1640 buffered with 10 mM Hepes at pH 7.4 and were supplemented with 20% FCS, 5 ,ug human transferrin, 200 mg/liter HaHCO3, 100 U/ml penicillin, and 100,gg/ml streptomycin. Once confluent, the cells were passaged after incubation with 0.5 ml 0.25% trypsin and 0.01% EDTA for 10 min at 370C. Studies were performed on GMC monolayers at 4th through 10th passage.
Experimental design
When confluent, GMC monolayers were exposed to one of four test culture media described below.
Control medium. This comprised standard GMC culture medium as described above (D-glucose concentration 5 Lowry (36) .
Assay ofprostaglandins and thromboxane
The quantity of PGE2, 6-keto PGFIa (the stable metabolite of PGI2 or prostacyclin), and TXB2 (the stable metabolite of TXA2) in the GMC supernatants was determined using an ELISA technique as described by Pradelles et al. (37) . Briefly, 50-Ml aliquots of the GMC supernatant were assayed without prior purification. 50 
Effect of test media on [3H]arachidonate reincorporation by GMC
The quantity of [3H ] arachidonate measured in the medium overlying the GMC monolayer is determined not only by its rate of release but also by its rate of reincorporation by GMC. To determine whether the test media influenced the rate of [3H ] arachidonate incorporation, GMC monolayers were preexposed to the various test media for 24 h. Thereafter, the medium was aspirated and replaced with a similar test medium supplemented with 0.5 UCi [ 3H ] arachidonate for 30 min. The radioactive medium was then removed and retained for scintillation counting. The GMC monolayers were washed rapidly (10 x 1 ml PSS plus 0.1% BSA), solubilized, and an aliquot of the cell solution was taken for counting of the radioactivity incorporated by GMC. The quantity of [3H]arachidonic acid incorporated by GMC per 30 min was expressed as a percentage of total radioactivity available for incorporation (i.e., radioactive supernatant counts plus GMC associated counts).
Measurement ofPKC activity in GMC PKC activity in GMC monolayers was measured using a modification of the method recently described by Heasley and Johnson (39, 40) . This method has been validated previously in our laboratory and used to characterize in situ PKC activation in cultured vascular smooth muscle cells (33) . GMC were seeded onto flat-bottomed 96-well microtiter plates at a density of -20,000/well and maintained in regular growth medium for 3 d until confluent. GMC monolayers were then incubated with the test media for 3 or 24 h. After incubation, the test medium was aspirated and replaced with 40 !d of a buffered salt solution containing 137 mM NaCl, 5.4 mM KCl, 10 mM MgCl2, 0.3 mM sodium phosphate, 0.4 mM potassium phosphate, 25 mM f3-glycerophosphate, 5.5 mM D-glucose, 5 mM EGTA, 1 mM CaCl2 ( _ 100 nM free Ca2+), 100 ,M [r-32P]ATP ( -5,000 cpm/pmol), 50 Mg/ml digitonin, and 20 mM Hepes (pH 7.2, 37°C). In addition, 100 ,M of a PKC-specific peptide substrate (VRKRTLRRL) was added to the buffer. This short synthetic peptide is based on the sequence surrounding a major PKC-dependent phosphorylation site within the epidermal growth factor receptor (41) . This peptide substrate is not phosphorylated by cyclic nucleotide-dependent or Ca2+/calmodulin-dependent protein kinases or S6 kinase and has been extensively characterized to be highly specific for PKC (39, 40) . By permeabilizing the GMC with the digitonin contained in the buffer, the VRKRTLRRL peptide enters the GMC along with [T-32PJATP to allow a highly selective and rapid analysis of in situ PKC activity. Similar to our findings with vascular smooth muscle cells, the concentration of digitonin used (50 ,g/ml)
did not modify GMC morphology or promote cell detachment. In addition, PKC activity was retained by the monolayer after permeabilization (PKC activity in supernatant was 7.3% of total measured PKC activity). This latter finding is consistent with the concept that the PKC activity being assayed was tightly associated with the cell membrane as has been proposed for the active form of the kinase (42) . The kinase reaction was linear for up to 20 min and was thus allowed to proceed for 10 min at 30'C before termination ofthe assay by the addition of50 yM ice cold 25% (wt/vol) trichloracetic acid (final TCA concentration 5%). Aliquots (45 Mi) of the acidified reaction mixture were then spotted onto 2-cm phosphocellulose paper circles (P81; Whatman Inc., Clifton, NJ) and washed batchwise; three washes with 75 mM phosphoric acid and one wash with 75 mM sodium phosphate (pH 7.5) (500 ml/2-min wash). Due to the basicity ofthe VRKRTLRRL substrate, it was retained by the phosphocellulose filter at neutral pH, while contaminating [r-32P]ATP was removed. The PKC-dependent phosphorylation of the peptide substrate bound to the filter was quantified by scintillation counting. Background phosphorylation was assessed in two ways: (a) Immediately before the addition of the reaction buffer, 40 ml of ice cold TCA was added to precipitate cellular protein and eliminate kinase activity. The TCA was aspirated, the reaction buffer was added, and the assay was performed as described above to determine the kinase-independent phosphorylation of the VRKRTLRRL substrate. (b) To determine background phosphorylation ofsubstrates other than VRKRTLRRL, the assay was performed in the absence of VRKRTLRRL. In both instances, background phosphorylation was always < 0.05% of added cpm and not different in GMC that had been exposed to any of the test (Fig. 1) . Furthermore, the fact that the medium containing the poorly metabolized glucose isomer (L-glucose) did not influence eicosanoid production suggests that the intracellular metabolism of D-glucose was essential for glucose-induced changes in GMC eicosanoid production to occur. Glucose concentration dependency ofchanges in GMC eicosanoid production. Fig. 2 shows that glucose-induced increases in GMC-PGE2 production were glucose concentration dependent up to a threshold glucose concentration of 20 mM. A similar profile of glucose concentration dependence was observed for GMC 6-keto-PGFia and TXB2 production (data not shown). The time dependency of glucose-induced increases in GMC eicosanoid production was similar for all three, requiring at least 2-h exposure to the high glucose medium before significant increases in basal eicosanoid production rates occurred.
Effect of exogenous arachidonic acid on PGE2 production by GMC. The fact that high extracellular glucose concentrations increased the basal production rates of all eicosanoids by a similar order of magnitude implies that glucose acted to in- Glucose concentration dependency of PGE2 production by GMC measured after 24-h exposure to culture media containing various concentrations ofD-glucose. *P < 0.01 vs glucose 5 mM, n = 3.
crease the availability of a common substrate for their synthesis, notably arachidonic acid. The next series of studies thus examined the effect ofelevated extracellular glucose concentrations on endogenous arachidonic acid release by GMC. Table I shows that supplementing the control or high glucose media with exogenous arachidonic acid (30 ,M) eliminated the high glucose-induced increase in PGE2, suggesting that glucose-induced increases in GMC eicosanoid production primarily resulted from enhanced availability of endogenous arachidonic acid.
Effects of test media on [3H]arachidonic acid release by
GMC. To examine specifically whether high glucose concentrations directly enhanced the release of endogenous arachidonic acid from GMC, the release of [3H]arachidonate from preloaded GMC was examined. Fig. 3 shows that 3-h incubation with the high glucose medium induced a marked and significant increase in endogenous arachidonic acid release by GMC ( 177% vs control medium). This effect was sustained with prolonged exposure to the high glucose medium for 24 h. In contrast, 24-h exposure to the osmotic control media did not reproduce the effect of the high glucose medium. Effect ofextracellularglucose concentration on reincorporation ofarachidonic acid by GMC. To determine whether glucose stimulated the release of arachidonic acid from GMC, rather than inhibited arachidonic acid reincorporation, GMC were exposed to control or high glucose medium for 24 h.
Thereafter, the incorporation of [ 3H] arachidonic acid by (30, 32, 33) . Furthermore, PKC activation directly via phorbol esters, or via hormonal stimulation, has been shown to augment arachidonic acid release and prostaglandin production by various cell types (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) . Thus, the next series of studies examined whether PKC activation was involved in the mechanism(s) whereby glucose stimulated increased arachidonic acid release and increased eicosanoid production by GMC. Fig. 4 shows that after 3-h exposure to high D-glucose (20 mM) medium, in situ PKC activity was markedly increased compared to the PKC activity measured in GMC exposed to control medium (n-glucose 5 mM) and was sustained for up to 24 h with continued exposure to the high glucose medium. In contrast, 24-h exposure to the two osmotic control media produced no appreciable stimulation of in situ PKC activity, confirming that PKC activation was not osmotically mediated but did require the increased metabolism of n-glucose (Fig. 4) . The glucose concentration dependency of PKC activation in GMC is shown in Fig. 5 . Maximal glucose-induced PKC activation was observed at a glucose concentration of 20 mM.
To evaluate the role of PKC activity in mediating glucoseinduced increases in arachidonic acid release and eicosanoid production by GMC, two relatively specific but dissimilar inhibitors of PKC were used (H-7 and staurosporine) (44, 45 Figure 4 . Glucose-induced PKC activity in GMC monolayers. Confluent GMC monolayers were exposed to control (C) or high glucose (HG) medium for 3 and 24 h, or to L-glucose osmotic control medium (L-G) or mannitol osmotic control medium (M) for 24 h before measuring PKC activity. PKC activity was measured in situ in digitonin-permeabilized GMC by determining the phosphorylation of a PKC-specific peptide substrate (VRKRTLRRL). Results are expressed as picomoles phosphate transferred to this substrate per minute per milligram GMC protein (n = 4). had no effect on basal or glucose-stimulated PKC activity (data not shown). With control medium, H-7 at a concentration of 50 AM or staurosporine (1 MM) had little effect on basal PKC activity. However, when coincubated with the high glucose medium, both H-7 and staurosporine significantly inhibited glucose-induced PKC activation in GMC (Fig. 6 ).
The role ofPKC in glucose-induced changes in arachidonic acid release and prostaglandin production by GMC. Fig. 7 shows that in the absence ofPKC inhibitors, 3-or 24-h incubations with high glucose medium significantly augmented arachidonic acid release by GMC. However, when the high glucose medium was supplemented with either H-7 or staurosporine, glucose-induced increases in arachidonic acid release were prevented, suggesting that glucose-induced increases in arachidonic acid release by GMC are dependent on the capacity of glucose to activate PKC.
Increased arachidonic acid release is often taken to represent PLA2 activation. It was possible therefore that H-7-and staurosporine-induced inhibition of glucose-stimulated increases in arachidonic acid release represented nonspecific inhibition of PLA2 by these agents. To examine this possibility, GMC were preloaded with [3H]arachidonic acid for 24 h before a 30-min incubation with exogenous PLA2 (1 U/ ml)±H-7 or staurosporine. Table II shows that exogenous PLA2 significantly increased [3HIarachidonic acid release by GMC. The addition of H-7 or staurosporine did not inhibit PLA2-induced arachidonic acid release, confirming that the PKC inhibitors used in the present study did not nonspecifically inhibit PLA2 activity. The next study examined the effects of H-7 and staurosporine on glucose-induced increases in PGE2 production by GMC. Fig. 8 shows that exposing GMC to high glucose medium in the presence of either PKC inhibitor markedly attenuates the high glucose-induced increase in PGE2 production.
Together, these data demonstrate that high extracellular glucose concentrations directly increase eicosanoid production by GMC via glucose-induced increases in endogenous arachidonic acid release, which in turn depends on glucose-induced PKC activation in GMC.
Discussion
Mesangial cells are an abundant source of glomerular eicosanoids and the present study demonstrates that elevated extracel- lular glucose concentrations directly and independently increase the basal production rates of PGE2, PGI2, and TXA2 by cultured rat glomerular mesangial cells. This effect is apparent within hours ofexposure to high glucose and persists for at least 24 h with continued exposure. These observations are consistent with a previous report demonstrating that chronic exposure to a high glucose medium (30 mM) for 10-14 d increased the production of predominantly PGE2 by cultured rat GMC (9) . Until now however, the mechanism underlying this potentially important action of glucose has remained undefined. In pursuit of such a mechanism, the present study demonstrates that elevated extracellular glucose concentrations directly increase endogenous arachidonic acid release by GMC. The regulation of endogenous arachidonic acid release by GMC is complex and rate limiting for eicosanoid production (16) . Recent evidence suggests an important role for PKC in the regulation ofarachidonic acid release ( 17-26). Specifically, PMA, which binds to and activates PKC, has been shown to simulate arachidonic acid release and eicosanoid production by many cell types including the mesangial cell (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) . Additional studies support a role for PKC in the hormonal regulation of glomerular arachidonic acid release and PGE2 production (25) (26) (27) . The present study demonstrates that elevated The glucose concentration required for maximal PKC activation (20 mM) in GMC is compatible with blood glucose concentrations attained in experimental models of diabetes mellitus and poorly controlled diabetic patients. Moreover, the striking similarity between the concentration dependency of glucose-induced changes in PKC activity and GMC eicosanoid production suggests that these two events could be causally related. Concordant with this hypothesis, the present study demonstrates that two chemically dissimilar inhibitors of glucose-induced PKC activation, H-7 and staurosporine, prevented both the glucose-induced increase in arachidonic acid release and eicosanoid production by GMC, suggesting that glucose-induced changes in eicosanoid metabolism may be mediated via glucose-induced PKC activation. However, as neither H-7 nor staurosporine are totally specific in their inhibition of PKC, the role of concomitant inhibition of other kinases by these inhibitors cannot be excluded.
In most cell types, PLA2 is believed to be the primary effector enzyme for arachidonic acid release ( 16) and in this regard,
[3H ]arachidonic acid release rates are often considered to be representative of PLA2 activity. PKC has been shown to increase PLA2 activity in many cell types, either by phosphorylation of a 40-kD regulatory protein indistinguishable from lipocortin, and/or direct phosphorylation and posttranslational modification of PLA2 (47) (48) (49) . PKC-induced activation of PLA2 could thus explain the PKC-dependent effect of glucose to increase arachidonic acid release by GMC. In this regard, PLA2 activity was shown to be increased in glomeruli isolated from diabetic rats, when compared to glomerular PLA2 activity in control rats ( 15) . Moreover, the diabetic glomeruli also released more arachidonic acid and eicosanoids suggesting that the increased PLA2 activity was of physiologic significance. The results of the present study complement and extend these observations by indicating that high extracellular glucose concentrations is likely the key mediator of increased glomerular arachidonic acid release and eicosanoid synthesis in these diabetic animals, as a direct consequence of PKC-mediated modulation of PLA2 activity. These observations do not, however, exclude the possibility that diabetes-induced increases in glomerular eicosanoid synthesis could also occur as a consequence of additional changes in cyclooxygenase activity (8) .
Glucose-induced increases in GMC eicosanoid production could have considerable pathophysiologic significance. Early diabetes mellitus is characterized by the development of glomerular hyperfiltration and these hemodynamic changes have been strongly implicated in the pathogenesis of diabetic glomerulopathy (50) (51) (52) . Several studies suggest that increased glomerular production of the vasodilator prostaglandins PGE2 and PGI2 contributes to the early development of glomerular hyperfiltration in diabetes mellitus (12, 14, 53) . Hyperglycemia may be a key mediator of prostaglandin-mediated hyperfiltration, as illustrated by the fact that perfusion of isolated rat kidneys with high glucose concentrations increases GFR via a prostaglandin-dependent mechanism (54) . The results of the present in vitro study demonstrate a novel cellular mechanism whereby elevated glucose concentrations could directly increase glomerular prostaglandin production and thus could impact the regulation of GFR.
In addition to their effects on glomerular hemodynamics, PGE2, PGI2, and TXA2 also modify GMC proliferation (55, 56) . It is possible therefore, that glucose-induced changes in eicosanoid production by GMC could also have powerful autocrine and paracrine effects on glomerular cell growth and thus could contribute to diabetes-associated glomerular growth abnormalities (57-59).
In conclusion, the present results demonstrate that glucoseinduced PKC activation in GMC may provide an important link between the diabetic state and abnormalities in glomerular eicosanoid production. Specifically, we have shown that glucose directly increases arachidonic acid release and eicosanoid production GMC via a PKC-dependent mechanism. On this background, we propose that these effects occur via PKC-induced activation of PLA2. In so doing, glucose-induced PKC activation provides a novel mechanism that directly implicates hyperglycemia in the dysregulation of glomerular arachidonic acid release and eicosanoid production that may ultimately impact glomerular function and growth and contribute to the development of diabetic glomerulopathy.
